Business Description
Reshape Lifesciences Inc
NAICS : 334510
SIC : 3845
ISIN : US76090R2004
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.02 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -84.82 | |||||
Beneish M-Score | -1.7 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -78.4 | |||||
3-Year EBITDA Growth Rate | 78.1 | |||||
3-Year EPS without NRI Growth Rate | 76.7 | |||||
3-Year FCF Growth Rate | 70.8 | |||||
3-Year Book Growth Rate | -50.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 69.74 | |||||
14-Day RSI | 57.75 | |||||
6-1 Month Momentum % | 118.09 | |||||
12-1 Month Momentum % | -73.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.73 | |||||
Quick Ratio | 1.74 | |||||
Cash Ratio | 1.18 | |||||
Days Inventory | 403.88 | |||||
Days Sales Outstanding | 84.89 | |||||
Days Payable | 202.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -56.1 | |||||
Shareholder Yield % | -259.72 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 63.93 | |||||
Operating Margin % | -168.68 | |||||
Net Margin % | -131.22 | |||||
FCF Margin % | -195.9 | |||||
ROE % | -204.05 | |||||
ROA % | -98.44 | |||||
ROIC % | -486.15 | |||||
ROC (Joel Greenblatt) % | -684.01 | |||||
ROCE % | -193.5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.06 | |||||
PB Ratio | 0.58 | |||||
Price-to-Tangible-Book | 0.59 | |||||
EV-to-EBIT | 0.03 | |||||
EV-to-EBITDA | 0.03 | |||||
EV-to-Revenue | -0.03 | |||||
EV-to-Forward-Revenue | 0.01 | |||||
EV-to-FCF | 0.02 | |||||
Price-to-Net-Current-Asset-Value | 0.62 | |||||
Price-to-Net-Cash | 8.79 | |||||
Earnings Yield (Greenblatt) % | 3333.33 | |||||
FCF Yield % | -436.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Reshape Lifesciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8.052 | ||
EPS (TTM) (€) | -3.41 | ||
Beta | 0 | ||
Volatility % | 160.63 | ||
14-Day RSI | 57.75 | ||
14-Day ATR (€) | 0.00001 | ||
20-Day SMA (€) | 0.615 | ||
12-1 Month Momentum % | -73.03 | ||
52-Week Range (€) | 0.222 - 3.5 | ||
Shares Outstanding (Mil) | 23.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Reshape Lifesciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Reshape Lifesciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Reshape Lifesciences Inc Frequently Asked Questions
What is Reshape Lifesciences Inc(STU:24O0)'s stock price today?
When is next earnings date of Reshape Lifesciences Inc(STU:24O0)?
Does Reshape Lifesciences Inc(STU:24O0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |